SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing ...

Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes First conceptual model demonstrating the impact of BK polyomavirus on the health-related ...

Allegro NV, a biomedical company developing transformative nanotechnology treatments for degenerative joint disease, will officially launch production of its first microparticle hydrogel after a ...

Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to Gefion, Denmark’s flagship AI supercomputer ...

The ZOOTED | THCA Live Resin Disposable Vape | 1G is now available through The Hemp Doctor’s online store and at its North Carolina retail locations. Bulk and wholesale orders are also available ...

To schedule a 1on1 investor meeting with Valneva, institutional investors and analysts can contact Valneva’s investor relations department at [email protected].

Tecan reports return to sales growth and strong order entry in the second half of 2025 Group sales of CHF 882.5 million, down 1.6% in local currencies for the year, with second-half sales growth of ...

Jefferies, TD Cowen and Piper Sandler are acting as joint book-running managers for the offering. Wedbush PacGrow and LifeSci Capital are acting as passive bookrunners for the offering.

True Keto Fusion Keto+ ACV Gummies enters the 2026 market as one option within the expanding BHB-ACV hybrid supplement category. The product combines ingredients that have individually attracted ...

Bright Green Corporation (OTC: BGXXQ) and its Chief Executive Officer, Lynn Stockwell, today announced the filing of a landmark lawsuit seeking damages in excess of $3 billion against Rodey Law ...

Deliveries under this order will take place in 2026. This order includes a one-year base period, with two additional option periods for 2027 and 2028.

ClinNEXUS management will be in attendance during “JPM Week” hosting investor meetings and sharing its new corporate presentation- LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ClinNEXUS, (or the ...